Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-21-019723)

Filing Details

Accession Number:: 0001127602-21-019723
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-06-11 16:38:16
Reporting Period:: 2021-06-10

Accepted Time:: 2021-06-11 16:38:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1520262	Alkermes Plc.	ALKS	Pharmaceutical Preparations (2834)	981007018

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1675905	Joseph David Gaffin	852 Winter Street Waltham MA 02451	Svp, Clo, Alkermes, Inc.	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2021-06-10	13,500	$16.55	88,097	No	4	M	Direct
Ordinary Shares	Disposition	2021-06-10	13,500	$25.00	74,597	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Employee Stock Option (Right to Buy)	Disposition	2021-06-10	13,500	$0.00	13,500	$16.55

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
14,000		2022-05-21	No	4	M	Direct

Footnotes

This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
These options are fully vested in accordance with their terms.